期刊文献+

PRELPshRNA稳定转染Saos-2细胞系的构建及鉴定

Establishment and identification of Saos-2 sublines with stable transfection of PRELP shRNA
原文传递
导出
摘要 目的构建PRELP(proline/arginine-rich end leucine-rich repeat protein)基因sh RNA慢病毒表达载体,并对其在Saos-2细胞中沉默效果进行鉴定。方法针对PRELP m RNA设计2对干扰序列,化学合成后插入至慢病毒载体,将慢病毒载体以不同MOI值分别转染Saos-2细胞,筛选细胞内GFP阳性率最高MOI值。将合成的慢病毒载体以筛选出的MOI值分别转染细胞,嘌呤霉素筛选稳定转染细胞株,Western blot法验证两株稳定转染细胞株PRELP下调效率。结果成功构建PRELP sh RNA慢病毒载体,当MOI为50-70时,细胞内荧光蛋白表达阳性率最高;嘌呤霉素筛选到稳定转染的细胞株;构建的稳转细胞系均特异性抑制PRELP蛋白的表达。结论成功构建了PRELP sh RNA慢病毒载体,并建立稳定的Saos-2细胞PRELP下调表达细胞模型,为研究PRELP在骨关节炎中的作用奠定了基础。 Objective To construct the expression vector for proline/arginine-rich end leucine-rich repeat protein(PRELP) sh RNA and identify its silencing effect in Saos-2 cells. Methods Two pairs of interfering sequences were designed according to the m RMA sequences of PRELP, synthesized chemically and inserted into lentivirus vector, with which Saos-2 cells were transfected at various MOIs, and the MOI at which the positive rate of GFP in cells was the highest was screened. Saos-2 cells were transfected with the constructed lentivirus vector at the screened MOI, from which the stably transfected strains were screened with puromycin. The down-regulation efficacy of PRELP in two stably transfected cell strains were verified by Western blot. Results The lentivirus vector for PRELP sh RNA was constructed successfully. When the MOI was 50, the positive rate of GFP in cells reached the maximum. Stably transfected cell strains were obtained by screening with puromycin, in which the expression of PRELP was significantly inhibited. Conclusion The lentiviral expression vector for PRELP sh RNA was constructed successfully, and the Saos-2 cell model with downregulated expression of PRELP was established, which laid a foundation of study on role of PRELP in osteoarthritis.
出处 《中国生物制品学杂志》 CAS CSCD 2016年第4期365-368,373,共5页 Chinese Journal of Biologicals
基金 国家自然科学基金(81371909) 十二五国家科技支撑计划(2013BAI07B01)
关键词 PRELP RNA干扰 稳定转染 SAOS-2细胞 PRELP RNA interference Stable transfection Saos-2 cells
  • 相关文献

参考文献13

  • 1B E NGTSSON E,NEAME P J,HEINEG?RD D,et al.The primary structure of a basic leucine-rich repeat protein,PRELP,found in connective tissues[J].J Biol Chem,1995,270(43):25639-25644.
  • 2IOZZO R V.The biology of the small leucine-rich proteoglycans functional network of interactive proteins[J].J Biol Chem,1999,274(27):18843-18846.
  • 3LEWIS M.PRELP,collagen,and a theory of HutchinsonGilford progeria[J].Ageing Res Rev,2003,2(1):95-105.
  • 4BENGTSSON E,ASPBERG A,HEINEG魡D D,et al.The amino-terminal part of PRELP binds to heparin and heparan sulfate[J].J Biol Chem,2000,275(52):40695-40702.
  • 5RUCCI N,RUFO A,ALAMANOU M,et al.The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-κB inhibitor that impairs osteoclastogenesis[J].J Cell Biol,2009,187(5):669-683.
  • 6王嵩,赵秋枫.老年性骨关节病影像学研究的现状与进展[J].实用老年医学,2011,25(4):277-280. 被引量:1
  • 7韩金祥,周小艳.骨骼系统罕见病研究[M].山东济南:山东大学出版社,2013:73-75.
  • 8WAKKACH A,ROULEAU M,BLIN-WAKKACH C.Osteoimmune interactions in inflammatory bowel disease:central role of bone marrow Th17 TNFαcells in osteoclastogenesis[J].Front Immunol,2015,6:640.
  • 9刘弼,马经野,肖德明.骨关节炎中关节软骨和周围骨的变化[J].骨科,2011,2(3):163-165. 被引量:3
  • 10EVA B.Structure and interactions of the extracellular matrix protein PRELP[M].Lund:Lund University Publications,1999:28543-28553.

二级参考文献24

  • 1Murphy CL,,Thoms BL,Vaghjiani RJ,et al.Hypoxi-a.HIF-mediated articular chondrocyte function:pros-pects for cartilage repair. Arthritis Research and Therapy . 2009
  • 2Goldring MB,Marcu KB.Cartilage homeostasis inhealth and rheumatic diseases. Arthritis Research and Therapy . 2009
  • 3Kwan Tat S,Lajeunesse D,Pelletier JP,et al.Targe-ting subchondral bone for treating osteoarthritis:whatis the evidence?. Best Practice and Research Clinical Gastroenterology . 2010
  • 4Bingham CO3rd,Buckland-Wright JC,Garnero P,etal.Risedronate decreases biochemical markers of carti-lage degradation but does not decrease symptoms orslow radiographic progression in patients with medialcompartment osteoarthritis of the knee:results of thetwo-year multinational knee osteoarthritis struc. Arthritis and Rheumatism . 2006
  • 5Blaney Davidson EN,,van der Kraan PM,van den BergWB.TGF-beta and osteoarthritis. Osteoarthritis Carti-lage . 2007
  • 6Shane Anderson A,Loeser RF.Why is osteoarthritisan age-related disease?. Best Practice and Research Clinical Gastroenterology . 2010
  • 7Marcu KB,Otero M,Olivotto E,et al.NF-kappaBsignaling:multiple angles to target OA. Curr DrugTargets . 2010
  • 8Botter SM,Glasson SS,Hopkins B,et al.ADAMTS5-/-mice have less subchondral bone changes afterinduction of osteoarthritis through surgical instability:implications for a link between cartilage and subchon-dral bone changes. Osteoarthritis and Cartilage . 2009
  • 9Ijiri K,Zerbini LF,Peng H,et al.Differential expression of GADD45beta in normal and osteoarthritic cartilage:potential role in homeostasis of articular chondrocytes. Arthritis and Rheumatism . 2008
  • 10G Murphy,H Nagase.Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?. Nat Clin Pract Rheumatol . 2008

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部